On semaglutide, female participants lost 18.0%, compared to 11.0% for male participants (Source: SURMOUNT-5 Trial Sub-analysis, 2025)
Clinical trials are designed around percent body weight reduction, achievement of predefined thresholds such as 10 or 15 percent loss, and improvements in obesity-related comorbidities
This is when clients often report: A noticeable reduction in inches Less puffiness in the face A flatter midsection Increased motivation to move more When hunger is under control, healthier choices feel easier
Wondering whats the best summer skincare routine for glowing, non-greasy skin
While semaglutide medications like Ozempic and Wegovy have gained popularity for weight loss, there are ongoing investigations into potential mental health risks, particularly with higher doses used for this off-label purpose